BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20143398)

  • 21. Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth.
    Taniguchi K; Ishizaki T; Ayada T; Sugiyama Y; Wakabayashi Y; Sekiya T; Nakagawa R; Yoshimura A
    Cancer Sci; 2009 Sep; 100(9):1648-54. PubMed ID: 19493272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression.
    Hu C; Dandapat A; Chen J; Liu Y; Hermonat PL; Carey RM; Mehta JL
    Atherosclerosis; 2008 Aug; 199(2):288-94. PubMed ID: 18096165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natriuretic peptide receptor A signaling regulates stem cell recruitment and angiogenesis: a model to study linkage between inflammation and tumorigenesis.
    Mallela J; Ravi S; Jean Louis F; Mulaney B; Cheung M; Sree Garapati U; Chinnasamy V; Wang C; Nagaraj S; Mohapatra SS; Mohapatra S
    Stem Cells; 2013 Jul; 31(7):1321-9. PubMed ID: 23533187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence and physiologic function of the renin-angiotensin system in mouse lacrimal gland.
    Yaguchi S; Ogawa Y; Shimmura S; Hatou S; Nakamura S; Inaba T; Imada T; Ozawa Y; Kawakami Y; Ishida S; Tsubota K
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5416-25. PubMed ID: 22786901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis.
    Sasaki K; Murohara T; Ikeda H; Sugaya T; Shimada T; Shintani S; Imaizumi T
    J Clin Invest; 2002 Mar; 109(5):603-11. PubMed ID: 11877468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of angiotensin II type-1 and type-2 receptors on vascular smooth muscle cell growth and glucose metabolism in diabetic rats.
    Igarashi M; Hirata A; Nozaki H; Kadomoto-Antsuki Y; Tominaga M
    Diabetes Res Clin Pract; 2007 Mar; 75(3):267-77. PubMed ID: 16934905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced sensitivity of the renal vasculature to angiotensin II in young rats: the role of the angiotensin type 2 receptor.
    Brown RD; Hilliard LM; Mirabito KM; Wirth LC; Moritz KM; Evans RG; Denton KM
    Pediatr Res; 2014 Nov; 76(5):448-52. PubMed ID: 25119338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet factor 4 gene transfection into tumor cells inhibits angiogenesis, tumor growth and metastasis.
    Yamaguchi K; Ogawa K; Katsube T; Shimao K; Konno S; Shimakawa T; Yoshimatsu K; Naritaka Y; Yagawa H; Hirose K
    Anticancer Res; 2005; 25(2A):847-51. PubMed ID: 15868918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade.
    Okada H; Inoue T; Kikuta T; Watanabe Y; Kanno Y; Ban S; Sugaya T; Horiuchi M; Suzuki H
    Am J Pathol; 2006 Nov; 169(5):1577-89. PubMed ID: 17071582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
    Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Host deficiency in caveolin-2 inhibits lung carcinoma tumor growth by impairing tumor angiogenesis.
    Liu Y; Jang S; Xie L; Sowa G
    Cancer Res; 2014 Nov; 74(22):6452-62. PubMed ID: 25269481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation.
    Gali-Muhtasib H; Sidani M; Geara F; Mona AD; Al-Hmaira J; Haddadin MJ; Zaatari G
    Int J Oncol; 2004 May; 24(5):1121-31. PubMed ID: 15067333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted Disruption of JCAD (Junctional Protein Associated With Coronary Artery Disease)/KIAA1462, a Coronary Artery Disease-Associated Gene Product, Inhibits Angiogenic Processes In Vitro and In Vivo.
    Hara T; Monguchi T; Iwamoto N; Akashi M; Mori K; Oshita T; Okano M; Toh R; Irino Y; Shinohara M; Yamashita Y; Shioi G; Furuse M; Ishida T; Hirata KI
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1667-1673. PubMed ID: 28705794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin-(1-7) protects against the development of aneurysmal subarachnoid hemorrhage in mice.
    Shimada K; Furukawa H; Wada K; Wei Y; Tada Y; Kuwabara A; Shikata F; Kanematsu Y; Lawton MT; Kitazato KT; Nagahiro S; Hashimoto T
    J Cereb Blood Flow Metab; 2015 Jul; 35(7):1163-8. PubMed ID: 25757758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis.
    García-Quiroz J; Rivas-Suárez M; García-Becerra R; Barrera D; Martínez-Reza I; Ordaz-Rosado D; Santos-Martinez N; Villanueva O; Santos-Cuevas CL; Avila E; Gamboa-Domínguez A; Halhali A; Larrea F; Díaz L
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():215-22. PubMed ID: 24120914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis.
    Dong J; Grunstein J; Tejada M; Peale F; Frantz G; Liang WC; Bai W; Yu L; Kowalski J; Liang X; Fuh G; Gerber HP; Ferrara N
    EMBO J; 2004 Jul; 23(14):2800-10. PubMed ID: 15229650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.